# Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND Acceptance

- Source: PR Newswire M&A
- Published: 2026-11-19T07:06:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/evotec-and-bristol-myers-squibb-advance-strategic-protein-degradation-partnership-with-second-ind-acceptance-302945056.html
- Canonical: https://groundlevelnews.com/story/evotec-and-bristol-myers-squibb-advance-strategic-protein-degradation--e3c9f6/

FDA clearance expands partnered molecular glue pipeline Achievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high unmet need HAMBURG, Germany, Nov. 19, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO)...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
